In the most recent trading session, Adma Biologics (ADMA) closed at $18.67, indicating a +1.3% shift from the previous trading day.

ADMA continues to maintain momentum in 2025 after its stupendous performance in 2024. Strong demand for Asceniv should fuel growth.

Several lots of intravenous and subcutaneous immune globulin have been voluntarily withdrawn by the manufacturers as a precautionary measure due to increased reports of allergic/hypersensitivity type ...